1,348 results on '"Fichna, Jakub"'
Search Results
202. Opioid peptides in cancer
203. Biomarkers for Early Detection of Colitis-associated Colorectal Cancer - Current Concepts, Future Trends
204. IBS-Symptoms in IBD Patients—Manifestation of Concomitant or Different Entities
205. Expression of FFAR3 and FFAR4 Is Increased in Gastroesophageal Reflux Disease
206. Anti-Inflammatory Effect of Homo- and Heterodimers of Natural Enkephalinase Inhibitors in Experimental Colitis in Mice
207. Recent advances in inflammatory bowel disease therapy
208. 935 THE EXPRESSION PATTERN OF PROTEASE-ACTIVATED RECEPTOR -2 AND PURINERGIC RECEPTORS: P2RX2 AND P2RY2 IN PATIENTS WITH GERD AND BARRETT'S ESOPHAGUS.
209. A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice
210. Receptor GPR18 – struktura i rola w fizjologii oraz patofizjologii.
211. [ d-1-Nal 4]endomorphin-2 is a potent μ-opioid receptor antagonist in the aequorin luminescence-based calcium assay
212. Effect of potent endomorphin degradation blockers on analgesic and antidepressant-like responses in mice
213. Anti-inflammatory and antibacterial effects of human cathelicidin active fragment KR-12 in the mouse models of colitis: a novel potential therapy of inflammatory bowel diseases
214. Air Pollution Associates with Cancer Incidences in Poland
215. Free Fatty Acid Receptors as New Potential Targets in Colorectal Cancer
216. Single Nucleotide Polymorphisms in Colitis-Associated Colorectal Cancer: A Current Overview with Emphasis on the Role of the Associated Genes Products
217. Inflammatory Bowel Disease – From Bench to Bedside
218. Novel selective agonist of GPR18, PSB‐KK‐1415 exerts potent anti‐inflammatory and anti‐nociceptive activities in animal models of intestinal inflammation and inflammatory pain
219. Cyclic derivative of morphiceptin Dmt-cyclo-(D-Lys-Phe-D-Pro-Asp)-NH2(P-317), a mixed agonist of MOP and KOP opioid receptors, exerts anti-inflammatory and anti-tumor activity in colitis and colitis-associated colorectal cancer in mice
220. Enkefalinazy jako nowy cel farmakologiczny w leczeniu chorób czynnościowych i zapalnych przewodu pokarmowego
221. Brain‐derived neurotrophic factor is elevated in the blood serum of Crohn's disease patients, but is not influenced by anti‐TNF‐α treatment—A pilot study
222. What role do cannabinoids have in modern medicine as gastrointestinal anti-inflammatory drugs?
223. Traditional Chinese Medicine Da-Cheng-Qi-Tang Ameliorates Impaired Gastrointestinal Motility and Intestinal Inflammatory Response in a Mouse Model of Postoperative Ileus
224. Silver nanoparticles based on blackcurrant extract show potent anti-inflammatory effect in vitro and in DSS-induced colitis in mice
225. Biologic Therapy in Crohn’s Disease–What We Have Learnt So Far
226. Psychological stress – does it affect wound healing?
227. Charakterystyka wirusa SARS-CoV-2 i potencjalne farmakologiczne sposoby leczenia
228. Walnut Oil Alleviates Intestinal Inflammation and Restores Intestinal Barrier Function in Mice
229. Sa1805 BRAIN DERIVED NEUROTROPHIC FACTOR IS ELEVATED IN THE BLOOD SERUM OF CROHN'S DISEASE PATIENTS, BUT DOES NOT CORRELATE WITH THE DISEASE ACTIVITY SCORE.
230. Visualization of Estrogen Receptors in Colons of Mice with TNBS-Induced Crohn's Disease using Immunofluorescence
231. Zastosowanie modulatorów receptorów sfingozyno-1-fosforanu w leczeniu nieswoistych chorób zapalnych jelit
232. Association of a Variant of CNR1 Gene Encoding Cannabinoid Receptor 1 With Gilles de la Tourette Syndrome
233. Circadian rhythm abnormalities in patients with inflammatory bowel disease – association with adipokine profile
234. Free Fatty Acid Receptors as new potential therapeutic target in inflammatory bowel diseases
235. Postępowanie w chorobie Leśniowskiego-Crohna – step-up czy top-down?
236. Synthesis and biological evaluation of novel peripherally active morphiceptin analogs
237. Gastrointestinal Adverse Events of Cannabinoid 1 Receptor Inverse Agonists suggest their Potential Use in Irritable Bowel Syndrome with Constipation: A Systematic Review and Meta-Analysis
238. The Novel Endomorphin Degradation Blockers Tyr-Pro-DClPhe-Phe-NH2 (EMDB-1) and Tyr-Pro-Ala-NH2 (EMDB-2) Prolong Endomorphin-2 Action in Rat Ileum In Vitro
239. Synthesis and biological evaluation of cyclic endomorphin-2 analogs
240. Design, Synthesis and Pharmacological Characterization of Endomorphin Analogues with Non-Cyclic Amino Acid Residues in Position 2
241. The Influence of Opioids on Urokinase Plasminogen Activator on Protein and mRNA Level in MCF-7 Breast Cancer Cell Line
242. Characterization and distribution of NKD, a receptor for Drosophila tachykinin-related peptide 6
243. Synthesis and biological activity of N-methylated analogs of endomorphin-2
244. Positive allosteric modulation of endogenous delta opioid receptor signaling in the enteric nervous system is a potential treatment for gastrointestinal motility disorders.
245. Protease-Activated Receptors – Key Regulators of Inflammatory Bowel Diseases Progression.
246. Colonic inflammation induces changes in glucose levels through modulation of incretin system.
247. The association of the quality of sleep with proinflammatory cytokine profile in inflammatory bowel disease patients.
248. Identification of Endomorphin-1 and Endomorphin-2 Binding Sites in Human μ-Opioid Receptor by Antisense Oligonucleotide Strategy
249. Enzymatic degradation of endomorphins
250. Synthesis and Biological Activity of Endomorphin-2 Analogs Incorporating Piperidine-2-, 3- or 4-Carboxylic Acids Instead of Proline in Position 2
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.